ARCHIVES

FDA Accepts DCT Board’s Criteria For Approval Of New Drugs, Explains Plan for Early Action

This article is from The Cancer Letter archive.

Vol. 15 No. 07 | February 17, 1989

Download PDF Visit The Full Archive

Related Articles

Vectibix Non-Inferior to Erbitux In Wild-Type Metastatic Disease

October 25, 2013

Britol-Meyers Holds Taxol Briefings, Outlines Timetable

July 5, 1991

In Brief: Friedman Named FDA Deputy Commissioner; Parkinson To Lead CTEP; Walsh Resigns

September 22, 1995

Bush Signs HHS Appropriations; NCI Budget $4.188B After Administrative Rescission.

January 11, 2002

In Brief: Louise Strong Named President, AACR; Donald Coffey Is President-Elect

April 26, 1996

In Brief: ACS Appoints Directors For Government Relations And Grassroots Development

April 25, 1997